Log in Start free →
Today’s CSR movers
SRE 4.1 ▲ 1.2
ES 3.0 ▲ 0.8
EIX 3.1 ▲ 0.8
AMZN 4.7 ▲ 0.1
GS 2.3 ▼ 0.8
WEC 2.6 ▼ 1.2
ETR 2.9 ▼ 1.2
C 2.8 ▼ 1.2
PCG 2.9 ▼ 1.2
FOX 2.4 ▼ 1.5
—
—
Health Care · NASDAQ NASDAQ · IDXX

Idexx Laboratories

$563.81 -$3.61 -0.64% CLOSE 07.20.26 AFTER HOURS $563.81
Convergence score
3.9 / 5.0 BULLISH
+0.0 vs last report
Overall valuation
Overvalued
Aggregated across multiple horizons
Consensus target (12mo)
$722.62 +28.2%
Range $470.00 — $830.00
Sector
Health Care
NASDAQ · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 07.20.26
UV Convergence Score
REPORT 07.20.26
3.9
/ 5.0
BULLISH
Consensus signal A
4.0
Consensus signal B
4.0
Consensus signal D
4.0
Rating trend signal
4.1
Analyst average
3.9
Multi-signal aggregate How CSR works →
Day Range
$561.02 – $569.95
52W Range
$513.02 – $769.98
Volume
405.8K
Avg Vol
664.7K
Mkt Cap
$44.48B
P/E
41.58
EPS (TTM)
$13.56
Div Yield
—
Beta
1.55
Today's convergence

Convergence score sits at 3.9 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Overvalued
CSR direction
BULLISH
Last close
$563.81
Sector
Health Care
Valuation
Three horizons
UPDATED 07.20.26
Short term
0–3 MO
No target Moderate Buy
Medium term
3–12 MO
$751+33.2% Buy
Long term
12–36 MO
$257.80-54.3% Overvalued
Open valuation →
Analysts
Coverage & consensus
4 PANELS
Mean target (12mo)
$722.62 +28.2%
RANGE $470.00 — $830.00
Analyst consensus
Consensus rating Buy
Blended score 4.0 / 5
Analysts tracked 54
Open analysts →
Financials
Key metrics
LATEST
P/E
41.58
EPS (TTM)
$13.56
Mkt Cap
$44.48B
Div Yield
—
Beta
1.55
52W Range
$513.02 – $769.98
Open financials →
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in →
Valuation breakdown

Three horizons, one consensus.

UPDATED 07.20.26
Short term
0–3 MO
Moderate Buy
Consensus target
No target available

Current analyst consensus rating from Barchart.

Medium term
3–12 MO
Buy
Consensus target
$751 +33.2%
RANGE $640 – $830
$640NOW $563.81$830

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Overvalued
Consensus target
$257.80 -54.3%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Top-level breakdown
Valuation: PE Ratio: 41.58PEG Ratio: -DE Ratio: -
Free Cash Flow: $786.84MPB Ratio: -PS Ratio: -Dividend: -
Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 07.20.26
Analyst consensus RATING · SCORE · PANELS · ANALYSTS
Rating Blended score Panels Analysts
Buy 4.0 4 54
Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE
Coverage Low Mean Median High Upside
All panels $470.00 $722.62 $707.50 $830.00 +28.2%
Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL
Coverage SB B H S SS
All panels 4 11 9 0 1
Rating trend CURRENT VS 1M / 2M / 3M
Period Rating Avg Analysts
Current Moderate Buy 4.13 15
1 Mo Ago Moderate Buy 4.13 15
2 Mo Ago Moderate Buy 4.13 15
3 Mo Ago Moderate Buy 4.13 15
Most recent analyst action LATEST DESK ACTION
Date
7/14/2026
Firm
Weiss Ratings
Action
Downgrade
Rating
Hold (C+) ➝ Hold (C)
Target
—
Related links
Financials

Full financial snapshot.

UPDATED 07.20.26
Quote snapshot 15 FIELDS
Prev Close
$567.44
Open
$569.95
Day Low
$561.02
Day High
$569.95
Bid
$561.76
Ask
$564.80
52W Low
$513.02
52W High
$769.98
50D Avg
$555.14
200D Avg
$624.15
Volume
405.8K
Avg Vol
664.7K
10D Avg Vol
682.6K
52W Change
8.94%
S&P 52W Change
18.27%
Valuation ratios 10 FIELDS
P/E (TTM)
41.58
P/E (Fwd)
34.14
PEG (Fwd)
3.64
P/S
10.00
P/B
28.71
Book Value
$19.64
EV/Revenue
10.21
EV/EBITDA
29.36
Mkt Cap
44.48B
Enterprise Val
45.38B
Profitability & returns 6 FIELDS
Profit Margin
24.63%
Gross Margin
62.05%
Operating Margin
31.78%
EBITDA Margin
34.77%
Return on Assets
26.46%
Return on Equity
72.91%
Growth 3 FIELDS
Revenue Growth (YoY)
14.30%
Earnings Growth (YoY)
17.20%
Earnings Growth (Q)
14.70%
Balance sheet & cash flow 11 FIELDS
Total Revenue
4.45B
EBITDA
1.55B
Total Cash
200.53M
Total Debt
1.11B
Cash / Share
$2.54
Revenue / Share
$55.57
Free Cash Flow
786.84M
Operating CF
1.21B
Debt / Equity
71.04
Current Ratio
1.12
Quick Ratio
0.69
Dividend 5 FIELDS
Fwd Dividend
—
Dividend Yield
—
Payout Ratio
0.00%
5Y Avg Yield
—
Ex-Div Date
—
Share statistics 7 FIELDS
Shares Out
78.88M
Float
78.58M
Shares Short
1.94M
% Short of Float
2.81%
Short Ratio
2.88
% Held Insiders
0.22%
% Held Institutions
96.85%
Calendar & events 5 FIELDS
Next Earnings
2026-08-04
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-03-31
Last Split
2:1
Split Date
2015-06-16
Company 2 FIELDS
Industry
Diagnostics & Research
Employees
11,000